Unicel Architectural Announces Availability of ViuLite Glass-Encased Venetian Blinds
Unicel Architectural, a producer of vision and daylight control solutions, has declared the availability of its patented and new ViuLite product range.
The ViuLite also branded as integrated blinds, enwraps Venetian blinds inside glass to provide a privacy solution that does not require any maintenance.
ViuLite product
The latest ViuLite product range from Unicel mixes its specialty glazing engineering with that of the Pellini’s ScreenLine technology and market expertise for integrated blinds. ViuLite is a blind structure that is lastingly sealed and set within a double-glazed cavity to offer dust-less and maintenance free surroundings. With the inclusion of ViuLite in its product collection, Unicel currently produces a full range of blinded glazing and louvered product solutions for both interior and exterior design usages.
The ViuLite integrated blind systems offers several advantages such as tilt and raise or tilt only, motorized or manual controls, and variable vision control. The blinds provide clean and dust-less environment, does not require cleaning and maintenance and provide improved shading. Unlike normal blinds, the sealed blinds are protected from damages. The blinds are supplied in a choice of colors and the narrow 20mm airspace allows easy fitting into restricted glass pocket depths and supported by Unicel’s matchless customer service.
The company holds the license to produce Pellini ScreenLine products in North America and also remains as an exclusive distributor for the products in Canada.
Source: http://www.unicelarchitectural.com/
Written by
Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Scanlon, Joel. (2019, February 22). Unicel Architectural Announces Availability of ViuLite Glass-Encased Venetian Blinds. AZoBuild. Retrieved on February 05, 2026 from https://www.azobuild.com/news.aspx?newsID=13768.
MLA
Scanlon, Joel. "Unicel Architectural Announces Availability of ViuLite Glass-Encased Venetian Blinds". AZoBuild. 05 February 2026. <https://www.azobuild.com/news.aspx?newsID=13768>.
Chicago
Scanlon, Joel. "Unicel Architectural Announces Availability of ViuLite Glass-Encased Venetian Blinds". AZoBuild. https://www.azobuild.com/news.aspx?newsID=13768. (accessed February 05, 2026).
Harvard
Scanlon, Joel. 2019. Unicel Architectural Announces Availability of ViuLite Glass-Encased Venetian Blinds. AZoBuild, viewed 05 February 2026, https://www.azobuild.com/news.aspx?newsID=13768.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.